Cargando…
Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease
BACKGROUND: Hydroxyurea and blood transfusion therapies remain the main therapeutic strategies for Sickle cell disease. Preliminary data suggest substantial variation and inconsistencies in practice of these two therapeutic modalities in South Asia. In this systematic review we searched Medline, Coc...
Autores principales: | Darshana, Thamal, Rees, David, Premawardhena, Anuja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989007/ https://www.ncbi.nlm.nih.gov/pubmed/33757549 http://dx.doi.org/10.1186/s13023-021-01781-w |
Ejemplares similares
-
Sickle cell disease in Sri Lanka: clinical and molecular basis and the unanswered questions about disease severity
por: Darshana, Thamal, et al.
Publicado: (2020) -
Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial
por: Yasara, Nirmani, et al.
Publicado: (2020) -
A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic
por: Yasara, Nirmani, et al.
Publicado: (2021) -
Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010) -
Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)